Quthero is committed to the development of differentiated bioactive wound treatments with the potential to disrupt the $30B wound care market as the only wound dressings that enable both rapid and healthy healing with minimal scarring, in all wounds (surgical wounds, burns and chronic ulcers). Our immediate target market is cosmetic/plastic surgery, as self-pay, cash, market, with no current solutions for scar prevention and improved healing.